Andres Maldonado
Stock Analyst
(4.28)
# 4,648
Out of 4,648 analysts
61
Total ratings
54.1%
Success rate
15.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $40 | $14.81 | +170.09% | 12 | Oct 31, 2024 | |
| ERAS Erasca | Reiterates: Buy | $6 | $2.87 | +109.06% | 7 | Oct 25, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $18 | $3.40 | +429.41% | 1 | Oct 17, 2024 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $30 → $35 | $27.67 | +26.49% | 11 | Oct 8, 2024 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $36.78 | +103.92% | 6 | Sep 17, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $4 | $1.72 | +132.56% | 10 | Aug 12, 2024 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $2.26 | +563.72% | 14 | Jul 2, 2024 |
Day One Biopharmaceuticals
Oct 31, 2024
Reiterates: Buy
Price Target: $40
Current: $14.81
Upside: +170.09%
Erasca
Oct 25, 2024
Reiterates: Buy
Price Target: $6
Current: $2.87
Upside: +109.06%
Mural Oncology
Oct 17, 2024
Initiates: Buy
Price Target: $18
Current: $3.40
Upside: +429.41%
Scholar Rock Holding
Oct 8, 2024
Maintains: Buy
Price Target: $30 → $35
Current: $27.67
Upside: +26.49%
CG Oncology
Sep 17, 2024
Reiterates: Buy
Price Target: $75
Current: $36.78
Upside: +103.92%
Ikena Oncology
Aug 12, 2024
Reiterates: Buy
Price Target: $4
Current: $1.72
Upside: +132.56%
Werewolf Therapeutics
Jul 2, 2024
Reiterates: Buy
Price Target: $15
Current: $2.26
Upside: +563.72%